110 related articles for article (PubMed ID: 37209463)
21. Simultaneous T
Velasco C; Cruz G; Lavin B; Hua A; Fotaki A; Botnar RM; Prieto C
Magn Reson Med; 2022 Apr; 87(4):1992-2002. PubMed ID: 34799854
[TBL] [Abstract][Full Text] [Related]
22. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.
Maas MC; Litjens GJS; Wright AJ; Attenberger UI; Haider MA; Helbich TH; Kiefer B; Macura KJ; Margolis DJA; Padhani AR; Selnæs KM; Villeirs GM; Fütterer JJ; Scheenen TWJ
Invest Radiol; 2019 Jul; 54(7):437-447. PubMed ID: 30946180
[TBL] [Abstract][Full Text] [Related]
23. Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1.
Yang L; Li M; Zhang MN; Yao J; Song B
Eur J Radiol; 2022 May; 150():110268. PubMed ID: 35344914
[TBL] [Abstract][Full Text] [Related]
24. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.
De Visschere PJ; Vral A; Perletti G; Pattyn E; Praet M; Magri V; Villeirs GM
Eur Radiol; 2017 May; 27(5):2095-2109. PubMed ID: 27491874
[TBL] [Abstract][Full Text] [Related]
26. The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T
Sushentsev N; Kaggie JD; Buonincontri G; Schulte RF; Graves MJ; Gnanapragasam VJ; Barrett T
Sci Rep; 2020 Nov; 10(1):20475. PubMed ID: 33235229
[TBL] [Abstract][Full Text] [Related]
27. Quantitative imaging metrics derived from magnetic resonance fingerprinting using ISMRM/NIST MRI system phantom: An international multicenter repeatability and reproducibility study.
Shridhar Konar A; Qian E; Geethanath S; Buonincontri G; Obuchowski NA; Fung M; Gomez P; Schulte R; Cencini M; Tosetti M; Schwartz LH; Shukla-Dave A
Med Phys; 2021 May; 48(5):2438-2447. PubMed ID: 33690905
[TBL] [Abstract][Full Text] [Related]
28. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
[No Abstract] [Full Text] [Related]
29. Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.
Mueller-Lisse UG; Murer S; Mueller-Lisse UL; Kuhn M; Scheidler J; Scherr M
Eur Radiol; 2017 Aug; 27(8):3362-3371. PubMed ID: 28058480
[TBL] [Abstract][Full Text] [Related]
30. Inter-Reader Variability Using PI-RADS v2 Versus PI-RADS v2.1: Most New Disagreement Stems from Scores 1 and 2.
Beetz NL; Haas M; Baur A; Konietschke F; Roy A; Hamm CA; Rudolph MM; Shnayien S; Hamm B; Cash H; Asbach P; Penzkofer T
Rofo; 2022 Aug; 194(8):852-861. PubMed ID: 35545106
[TBL] [Abstract][Full Text] [Related]
31. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
[TBL] [Abstract][Full Text] [Related]
32. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
33. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study.
Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
36. Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.
Viswanath SE; Bloch NB; Chappelow JC; Toth R; Rofsky NM; Genega EM; Lenkinski RE; Madabhushi A
J Magn Reson Imaging; 2012 Jul; 36(1):213-24. PubMed ID: 22337003
[TBL] [Abstract][Full Text] [Related]
37. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
[TBL] [Abstract][Full Text] [Related]
38. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
39. Toward magnetic resonance fingerprinting for low-field MR-guided radiation therapy.
Mickevicius NJ; Kim JP; Zhao J; Morris ZS; Hurst NJ; Glide-Hurst CK
Med Phys; 2021 Nov; 48(11):6930-6940. PubMed ID: 34487357
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume.
Jung SI; Jeon HJ; Park HS; Yu MH; Kim YJ; Lee SE; Lim SD
Br J Radiol; 2018 Jun; 91(1086):20180001. PubMed ID: 29493284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
